PharmaShots | Incisive News in 3 Shots

Subscribe Now

Rani Therapeutics

Rani Therapeutics Collaborates with ProGen to Develop RT-114 for Obesity

Rani Therapeutics Collaborates with ProGen to Develop RT-114 for Obesity

June 25, 2024

Rani Therapeutics Reports the Results for RT-111 Capsules Containing CT-P43 (biosimilar, ustekinumab) in P-I Trial for the Treatment of Various Indications

Rani Therapeutics Reports the Results for RT-111 Capsules Containing CT-P43 (biosimilar, ustekinumab) in P-I Trial for the Treatme...

February 5, 2024

Rani Therapeutics Initiates P-I Study of RT-111 (biosimilar, ustekinumab) for Autoimmune Diseases

Rani Therapeutics Initiates P-I Study of RT-111 (biosimilar, ustekinumab) for Autoimmune Diseases

September 19, 2023

Rani Therapeutics Expands its Collaboration with Celltrion to Develop Oral Version of Humira Biosimilar RT-105

Rani Therapeutics Expands its Collaboration with Celltrion to Develop Oral Version of Humira Biosimilar RT-105

June 6, 2023

Rani Therapeutics Highlighted RT-111 Development Program for Multiple Indications

Rani Therapeutics Highlighted RT-111 Development Program for Multiple Indications

October 24, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us